Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market to Grow at a CAGR of 7.4% from 2025 to 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Covering 2025–2034?
The next-generation sequencing (NGS)-based molecular diagnostics market has shown robust growth recently. Its value is projected to climb from $2.10 billion in 2024 to $2.26 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.8%. The expansion observed historically stems from an escalated demand for personalized medicine, a greater integration of next-generation sequencing in clinical environments, heightened awareness among medical professionals and patients, the improved accessibility of affordable next-generation sequencing platforms, and the expanding utility in non-invasive prenatal testing.
The next-generation sequencing (NGS)-based molecular diagnostics market is anticipated to experience substantial expansion over the next few years, with projections indicating it will reach $3.01 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.4%. This growth during the forecast period can be attributed to an increasing need for decentralized diagnostic solutions, the rising integration of artificial intelligence in next-generation sequencing data interpretation, the escalating issue of antibiotic resistance, growing regulatory support for next-generation sequencing-based tests, and the expanding application of next-generation sequencing in pharmacogenomics. Key trends expected in this timeframe include technological advancements enhancing sequencing accuracy, automation driven by technology in sample preparation, integration with pharmaceutical development pipelines, the incorporation of next-generation sequencing into public health surveillance, and the development of specialized disease-specific next-generation sequencing panels.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28281&type=smp
Which Major Market Drivers Are Shaping The Future Of The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market?
The rising occurrence of infectious diseases is set to drive the expansion of the next-generation sequencing (NGS)-based molecular diagnostics market moving forward. These disorders, caused by microorganisms such as bacteria, viruses, fungi, or parasites, invade the body, multiply, and disrupt normal bodily functions. The prevalence of infectious diseases is increasing as greater travel and migration accelerate pathogen transmission across different regions and international borders. Next-generation sequencing (NGS)-based molecular diagnostics assists in detecting infectious diseases by offering comprehensive and precise pathogen analysis. It shortens diagnostic time by simultaneously identifying multiple microorganisms, which improves the accuracy of treatment and patient care. For instance, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis cases in England, a contagious bacterial infection primarily affecting the lungs, escalated to 4,850 in 2023, marking an increase of 10.7% from 4,380 cases in 2022. Thus, the growing incidence of infectious diseases is a significant factor propelling the growth of the next-generation sequencing (NGS)-based molecular diagnostics market.
What Are The Major Segment Categories Driving The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Growth?
The next-generation sequencing (NGS)-based molecular diagnostics market covered in this report is segmented as
1) By Type: Instruments, Reagents And Consumables, Software And Services, Panels And Assays, Sample Preparation Kits
2) By Application: Microbiology, Infectious Diseases, Oncology, Genetic Tests, Other Applications
3) By End User: Research Centers And Academics, Hospitals And Clinical Laboratories, Other End Users
Subsegments:
1) By Instruments: Benchtop Sequencers, High-Throughput Sequencers, Portable Or Handheld Sequencers, Clinical Or Diagnostic Sequencers, Automated Library Preparation Systems, Data Analysis And Bioinformatics Hardware
2) By Reagents And Consumables: Sequencing Reagents And Kits, Library Preparation Reagents, Target Enrichment Reagents, Amplification Reagents, Sequencing Flow Cells And Chips, Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents, Quality Control Reagents
3) By Software And Services: Data Analysis Software, Bioinformatics Pipelines, Cloud-Based Genomic Platforms, Clinical Interpretation Tools, Data Storage And Management Services, Custom Bioinformatics Services, Genomic Database Services
4) By Panels And Assays: Oncology Panels, Infectious Disease Panels, Carrier Screening Panels, Reproductive Health Panels, Rare Disease Or Genetic Disorder Panels, Pharmacogenomics Panels, Whole-Exome Or Whole-Genome Assays
5) By Sample Preparation Kits: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Library Preparation Kits, Target Enrichment Kits, Amplification And Cleanup Kits, Single-Cell Preparation Kits, Low-Input Or Degraded Sample Kits
How Are Emerging Market Trends Shaping The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Industry Landscape?
Leading companies in the next-generation sequencing (NGS)-based molecular diagnostics market are concentrating on developing technologically advanced products, such as NGS-based panels, to improve the accuracy, accessibility, and efficiency of genetic testing. Next-generation sequencing (NGS)-based panels are specific sets of genes or genomic regions that are analyzed simultaneously using NGS technology to detect particular hereditary or somatic mutations, leading to faster and more precise molecular diagnostics. For instance, in May 2022, Genes2Me Pvt. Ltd., an India-based medical equipment manufacturer, introduced a comprehensive range of next-generation sequencing (NGS)-based panels designed for oncology, personalized medicine, and hereditary disease diagnostics. These panels cover clinically significant genes with high sensitivity and extensive variant detection, including single-nucleotide variations, insertions or deletions, copy number variations, microsatellite instability, fusions, and oncogenic viruses, while also measuring tumor mutation burden. The Genes2Me PAN cancer panel covers around 525 genes, requires just 50 ng of nucleic acid, and offers streamlined workflows compatible with major NGS platforms.
Who Are The Major Companies Operating In The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market?
Major companies operating in the next-generation sequencing (ngs)-based molecular diagnostics market are Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., and TATAA Biocenter AB.
Download The Full Report For Exclusive Market Findings:
How Does The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Perform Across Key Geographic Regions?
North America was the largest region in the next-generation sequencing (NGS)-based molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next-generation sequencing (NGS)-based molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28281&type=smp
Browse Through More Reports Similar to the Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market 2025, By The Business Research Company
Clinical Next Generation Sequencing Ngs Data Analysis Global Market Report 2025
Ngs Based Rna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Next Generation Sequencing Market 2025
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
